Apr 28
|
2 Top Growth Stocks to Buy Right Now and Hold Forever
|
Apr 27
|
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.
|
Apr 26
|
Pioneer Institute study finds IRA discourages non-opioid drug innovation
|
Apr 26
|
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
|
Apr 26
|
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
|
Apr 25
|
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
|
Apr 25
|
2 Fantastic Growth Stocks to Buy Right Now
|
Apr 25
|
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
|
Apr 24
|
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
|
Apr 23
|
Health Care Roundup: Market Talk
|
Apr 23
|
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
|
Apr 23
|
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
|
Apr 23
|
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
|
Apr 22
|
10 Best Performing Biotech ETFs in 2024
|
Apr 22
|
Making Sense of Amazon CEO Andy Jassy's Latest Letter
|
Apr 22
|
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
|
Apr 22
|
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
|
Jan 25
|
Where Will Vertex Pharmaceuticals Be in 10 Years?
|
Jan 25
|
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
|
Jan 24
|
PBYI or VRTX: Which Is the Better Value Stock Right Now?
|